Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population

Proceedings of the National Academy of Sciences of the United States of America
Sharon SimchoniE Levy-Lahad

Abstract

Inherited mutations in BRCA1 and BRCA2 lead to significantly increased risks of breast and ovarian cancer. We used epidemiologic methods to evaluate the relative risks of breast cancer vs. ovarian cancer among women of Ashkenazi Jewish ancestry with inherited mutations in BRCA1 or BRCA2. The cancer of a family's index case (i.e., breast cancer vs. ovarian cancer) was significantly associated with site-specific risks of cancer in relatives known to carry mutations in BRCA1 or BRCA2. Specifically, breast cancer risks were higher among relatives of breast cancer index cases compared with relatives of ovarian cancer index cases [hazard ratio (HR) = 3.0, P < 0.001 for BRCA1 carriers and HR = 4.8, P = 0.017 for BRCA2 carriers], and ovarian cancer risks were higher among relatives of ovarian cancer index cases compared with relatives of breast cancer index cases (HR = 7.2, P = 0.001 for BRCA1 carriers and HR = 15.8, P = 0.018 for BRCA2 carriers). Breast and ovarian cancer risks also increased with more recent year of birth. For each later decade of birth, risk increased 1.2-fold (P = 0.03). Effects of cancer site of the index case and of birth cohort were independent. These results suggest that both genetic and nongenetic factors modi...Continue Reading

References

Apr 17, 1999·American Journal of Human Genetics·T R RebbeckM Brown
Nov 26, 1999·European Journal of Human Genetics : EJHG·R Gershoni-BaruchE Robinson
Jan 21, 2000·Genetic Epidemiology·A C AntoniouD F Easton
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·E Levy-LahadR Gershoni-Baruch
May 25, 2002·The New England Journal of Medicine·Noah D KauffKenneth Offit
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Mar 15, 2003·Nature Reviews. Cancer·Steven A Narod
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Luna KadouriRosalind A Eeles
Mar 4, 2005·Breast Cancer Research : BCR·Amanda B SpurdleUNKNOWN EMBRACE Study Collaborators
Mar 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven A Narod, Kenneth Offit
Nov 16, 2005·Human Mutation·Regina KroissUNKNOWN Austrian Hereditary Breast and Ovarian Cancer Group

❮ Previous
Next ❯

Citations

Oct 12, 2012·Human Genetics·Harry Ostrer, Karl Skorecki
Oct 11, 2011·Breast Cancer Research and Treatment·Shiri BernholtzEitan Friedman
Nov 25, 2011·Breast Cancer Research and Treatment·Shiri BernholtzEitan Friedman
Sep 23, 2008·Journal of Behavioral Medicine·Shoshana ShilohEitan Friedman
Apr 5, 2011·Journal of Mammary Gland Biology and Neoplasia·Andrew Y Shuen, William D Foulkes
Feb 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R L Milne, A C Antoniou
Aug 7, 2009·Human Molecular Genetics·Antonis C AntoniouUNKNOWN CIMBA
Sep 6, 2011·Human Molecular Genetics·David G CoxUNKNOWN Consortium of Investigators of Modifiers of BRCA1/2
Nov 26, 2010·Journal of the National Cancer Institute·Kelly MetcalfeUNKNOWN Hereditary Breast Cancer Clinical Study Group
Dec 21, 2010·Journal of the National Cancer Institute·Susan J RamusUNKNOWN Consortium of Investigators of Modifiers of BRCA1/2
Oct 21, 2009·Current Opinion in Obstetrics & Gynecology·Allison W Kurian
May 21, 2009·Annual Review of Genomics and Human Genetics·Guy RosnerAvi Orr-Urtreger
Dec 1, 2010·Breast Cancer Research : BCR·Logan C WalkerFergus J Couch
Jul 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrice WatsonJeffrey T Holt
Jan 11, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W KurianSylvia K Plevritis
Jan 16, 2013·Journal of Epidemiology·Wenming CaoJi-Cheng Li
Sep 16, 2011·Cancer Informatics·Simon ShermanKenneth Cowan
Feb 14, 2009·Breast Cancer Research and Treatment·Sarai Palanca SuelaUNKNOWN Group for Assessment of Hereditary Cancer of Valencia Community
Aug 17, 2010·Familial Cancer·Eva Esteban CardeñosaUNKNOWN Group for Assessment for Hereditary Cancer of Valencian Community
Apr 29, 2014·Lancet·Gordon C JaysonJonathan A Ledermann
Sep 12, 2013·Obstetrics and Gynecology Clinics of North America·Dana Meaney-Delman, Cecelia A Bellcross
Apr 20, 2010·Current Opinion in Genetics & Development·Antonis C Antoniou, Georgia Chenevix-Trench
Dec 17, 2008·Preventive Medicine·Efrat Dagan, Tamar Shochat
Jan 19, 2012·Human Mutation·Susan J RamusUNKNOWN Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Aug 17, 2016·Endocrine-related Cancer·Roger L Milne, Antonis C Antoniou
Oct 23, 2015·Qualitative Health Research·Orit Karnieli-MillerMiriam Goldberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.